glp-1 for minor weight loss Unlocking Sustainable with Weight Loss Medications and Peptides at Illume Med Spa Glp 1 Mechanism Infographic

Abstract Background: GLP-1 receptor agonists (GLP-1RAs) address key metabolic drivers of Polycystic Ovary Syndrome (PCOS), yet their integration into fertility management remains challenging because reproductive efficacy is variably reported, preconception washout is required, and standardized clinical pathways are lacking

For context, most GLP-1 medications require consistent use for weeks or months to start working at full therapeutic capacity

For a step-by-step overview of the process, how to get semaglutide for weight loss explains how a personalized program works from evaluation to treatment

Current evidence suggests there may be a link between GLP-1 medications and hair loss, particularly with semaglutide (Wegovy) and tirzepatide (Mounjaro), but researchers have not proven that the medication itself directly causes hair loss

BMI 25 to 30 (overweight) People starting in the overweight range can expect moderate but meaningful weight loss